Showing 2 results for Tayebi
Zahra Tayebi Myaneh, Farnoosh Rashvand, Fariba Abdolahi,
Volume 26, Issue 3 (9-2020)
Abstract
Background & Aim: Sleep disturbances in type II diabetes patients due to insulin resistance is a risk factor for the exacerbation of the disease. Therefore, assessment of the factors affecting the improvement of sleep in diabetic patients is a necessity for health care providers. The aim of this study was to investigate the relationship between sleep quality and self-management in type 2 diabetes patients.
Methods & Materials: This is a descriptive, cross-sectional study. A total number of 170 patients with type 2 diabetes referred to the medical centers affiliated to Qazvin University of Medical Sciences were included using the convenience sampling method in 2018-2019. Data were collected by the Richards-Campbell Sleep Questionnaire (RCSQ) and the Diabetes Self-management Questionnaire (DSMQ). Data were analyzed by the SPSS software version 21 using the descriptive/analytical statistics.
Results: The results showed that the mean score of sleep quality was 49.89±25.90 (range: 0-100) and mean score of self-management was 31.82±6.80 (range: 0-48). The results from the Pearson correlation analysis showed a significant relationship between sleep quality and self-management (P<0.05). Also, the stepwise linear regression model showed that the use of health care systems and physical activity and other variables such as marital status and weight of patients had a significant effect on their sleep quality (P<0.05).
Conclusion: The results of the study showed that an increase in the patients’ self-care status, use of health care systems, increased daily physical activity and having an ideal weight can be predictors in improving patients' sleep quality. Therefore, providing infrastructure programs such as continuing education and providing appropriate care programs for diabetics to improve self-management activities, as well as increasing daily physical activity, increasing the use of health systems, and weight control can improve the sleep quality of this group of patients who account for a significant proportion of chronic diseases in communities.
Ali Hosseinzadeh, Abolfazl Rahimi, Robabe Khalili, Ali Tayebi, Mohamad Nikpouraghdam,
Volume 31, Issue 4 (1-2026)
Abstract
Background & Aim: End-stage renal failure requires careful and effective planning in the hemodialysis process to improve patients' quality of life and reduce complications. Therefore, this study aimed to investigate the impact of using cold dialysis solution on sleep quality and blood pressure changes during hemodialysis in patients with end-stage renal failure.
Methods & Materials: This blinded randomized clinical trial included 82 patients undergoing hemodialysis in Baqiyatallah and Milad hospitals in Tehran in 2023. Patients were randomly assigned to either the intervention group (41 individuals) or the control group (41 individuals). The intervention group received hemodialysis with cold dialysis solution (35°C), while the control group received standard dialysis solution (37°C) for 4 weeks. Data was collected using a demographic and disease characteristics form, Richard Campbell Sleep Quality Questionnaire (RCSQ), and a mercury sphygmomanometer. Data analysis was conducted using SPSS version 26 software, utilizing Mann-Whitney, independent t-test, chi-square, and paired t-test.
Results: The mean sleep quality score in the cold hemodialysis group (35°) after dialysis was significantly higher than the standard group (37°) (P=0.004). No significant difference was observed between the two groups before dialysis (P=0.759). There was no significant difference between the mean systolic and diastolic blood pressure scores before dialysis in the two groups. However, after dialysis, the reduction in blood pressure (systolic and diastolic) in the cold hemodialysis group was significantly less than in the standard group (P<0.001).
Conclusion: The results of this clinical trial showed that the use of cold dialysis solution during hemodialysis significantly improved the sleep quality of patients with end-stage renal failure and reduced blood pressure changes during treatment. These findings can be used to improve the treatment process and enhance the quality of life of these patients.
Clinical trial registry: IRCT20230521058244N1
